Characterization of Small Genetic Variants in Breast Cancer Cell Line Under Tamoxifen Therapy

Area of Science:

• Genomics
• Oncology
• Pharmacogenomics

Background:

• Tamoxifen (TAM) is a crucial hormone therapy for reducing cancer recurrence.
• TAM's influence on genetic variants and its potential role in treatment efficacy require investigation.

Purpose of the Study:

• To investigate the effects of TAM on genomic features.
• To determine if TAM-induced genetic variant alterations are associated with effective cancer treatment.

Main Methods:

• Whole-transcriptome sequencing (RNA-seq) data from TAM-treated and untreated samples were analyzed.
• Variant calling and gene ontology enrichment analysis were performed using CLC Genomics Workbench.

Main Results:

• Approximately 5.8 million genetic variants were identified.
• 67 differential genetic variants were found between TAM-treated and control groups.
• Enrichment analysis linked these variants to key oncogenes and tumor suppressors (e.g., IL6ST, GEN1, FNTA).

Conclusions:

• Candidate genes with differential variants often possess dual oncogenic or tumor-suppressive roles.
• TAM-induced genetic variant alterations do not show a significant association with effective cancer treatment.
• The precise impact of TAM on treatment outcomes via genetic modifications remains inconclusive.